Sign Up to like & get
recommendations!
0
Published in 2021 at "Cardiovascular toxicology"
DOI: 10.1007/s12012-021-09701-x
Abstract: Administration of Chemotherapeutics, especially doxorubicin (DOX) and cyclophosphamide (CPS), is commonly associated with adverse effects such as myelosuppression and cardiotoxicity. At this time, few approved therapeutic options are currently available for the management of chemotherapy-associated…
read more here.
Keywords:
doxorubicin cyclophosphamide;
induced cardiotoxicity;
cyclophosphamide induced;
cardioprotective effects ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Clinical Drug Investigation"
DOI: 10.1007/s40261-018-0655-z
Abstract: BackgroundIn the era of personalized therapy, targeted treatment in specific patient populations is mandated.ObjectiveWe evaluated the efficacy and safety of neoadjuvant treatment on locally advanced breast cancer (LABC) with a monoclonal agent against vascular endothelial…
read more here.
Keywords:
doxorubicin cyclophosphamide;
breast;
neoadjuvant treatment;
treatment ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Veterinary and Comparative Oncology"
DOI: 10.1111/vco.12139
Abstract: Canine hemangiosarcoma (HSA) is a neoplasm of vascular endothelial origin that has an aggressive biological behaviour, with less than 10% of dogs alive at 12-months postdiagnosis. Treatment of choice consists of surgery followed by adjuvant…
read more here.
Keywords:
doxorubicin cyclophosphamide;
treatment;
doxorubicin dacarbazine;
doxorubicin ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "In Vivo"
DOI: 10.21873/invivo.12452
Abstract: Background: Thrombotic microangiopathy (TMA) is a clinical syndrome consisting of hemolytic anemia, thrombocytopenia, and presence of schistocytes on peripheral blood smear secondary to disorders of systemic microvascular thrombosis. Malignancy-associated TMA is a rare entity and…
read more here.
Keywords:
cancer;
doxorubicin cyclophosphamide;
thrombotic microangiopathy;
breast cancer ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Biomedicines"
DOI: 10.3390/biomedicines9020189
Abstract: Breast Cancer is still one of the most common cancers today; however, with advancements in diagnostic and treatment methods, the mortality and survivorship of patients continues to decrease and increase, respectively. Commonly used treatments today…
read more here.
Keywords:
chemotherapy;
doxorubicin cyclophosphamide;
nervous system;
breast cancer ... See more keywords